非洲队列研究中非感染性合并症分析
在肯尼亚、乌干达、坦桑尼亚和尼日利亚的11个HIV诊所,2720名参与者入组时接受评估,其中2159人HIV感染。HIV感染与更多非感染性合并症相关,尤其在ART使用者中;ART使用与更多NCDs独立相关,且与高胆固醇血症和血糖异常独立相关。
要点
- HIV感染者中37.7%至少有一种非感染性合并症。
- ART使用与更多NCDs独立相关(ARR 1.50,95%CI 1.27-1.78)。
- ART使用独立关联高胆固醇血症和血糖异常。
核心结论
- HIV感染是非感染性合并症的危险因素,在HIV感染者中常见且存在地理差异,与一线ART的代谢并发症基本一致。
研究设计与样本
- 在肯尼亚、乌干达、坦桑尼亚和尼日利亚的11个HIV诊所入组时进行医学史、体格、实验室和神经心理评估。
- 共2720名参与者有完整NCD数据,其中2159名(79.4%)为HIV感染者。
主要发现
- HIV感染者中,1426名(66.0%)正在使用ART,813名(37.7%)至少有一种NCD。
- HIV感染与更多NCDs相关,尤其在使用ART时(ARR 1.42;95% CI 1.22-1.66)。
- 在HIV感染者中,ART使用与更多NCDs相关(病毒学抑制者ARR 1.50;95% CI 1.27-1.78;病毒血症者ARR 1.38;95% CI 1.13-1.68)。
- 在使用ART的参与者中,CD4最低值低于200 cells/mm3与更多NCDs相关(ARR 1.43;95% CI 1.06-1.93)。
- 项目现场与除肾功能不全外的所有合并症显著相关。
临床怎么用
- 在非洲HIV感染者中应关注非感染性合并症的筛查与管理,尤其对ART使用者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Noninfectious comorbid diseases (NCDs) contribute to morbidity and mortality in human immunodeficiency virus (HIV)-infected populations in resource-rich countries. With antiretroviral therapy (ART) scale-up in Africa, understanding burden NCD informs public health strategy. METHODS: At enrollment, participants at 11 HIV clinics in Kenya, Uganda, Tanzania, and Nigeria underwent medical history, physical, laboratory, and neuropsychological assessments to identify elevated blood pressure, hypercholesterolemia, dysglycemia, renal insufficiency, and cognitive impairment. Poisson regression models estimated adjusted relative risks (ARRs) and 95% confidence intervals (CIs) for the number of NCDs associated with factors of interest. Logistic regression was used to evaluate each NCD separately among HIV-infected participants. RESULTS: Among 2720 participants with complete NCD data, 2159 (79.4%) were HIV-infected. Of those, 1426 (66.0%) were taking ART and 813 (37.7%) had at least 1 NCD. HIV infection was associated with more NCDs, especially with ART (ARR, 1.42; 95% CI, 1.22-1.66). In addition to age, body mass index, and program site, ART usage was associated with more NCDs (ARR, 1.50; 95% CI, 1.27-1.78 for virologically suppressed and ARR, 1.38; 95% CI, 1.13-1.68 for viremic) among HIV-infected participants. In participants taking ART, CD4 nadir below 200 cells/mm3 was associated with more NCDs (ARR, 1.43; 95% CI, 1.06-1.93). ART use was independently associated with hypercholesterolemia and dysglycemia. Program site was significantly associated with all comorbidities except renal insufficiency. CONCLUSIONS: HIV infection was a risk for NCDs, which were common in HIV-infected participants, geographically variable, and largely consistent with metabolic complications of first-line ART.
引用
- Ake JA, Polyak CS, Crowell TA, et al. Noninfectious Comorbidity in the African Cohort Study. Clin Infect Dis. 2019. PMID: 30476001. doi:10.1093/cid/ciy981
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。